Current Edition

Patient-centricity on Trial

The pharmaceutical industry has a problem; clinical trials are failing to recruit and retain the required number of patients at an alarming rate. The statistics are damning, with 46% of clinical trials failing due to poor recruitment and 80% of trials being delayed by at least one month. Will Wilson, Kristian Webb and Mark Evans at Havas Lynx Faze and Vernon Bainton at Havas Lynx Group investigate how underperformance in these key areas can be improved through a patient-centric approach to boost the success of clinical trials.